2Loehrer PJ, Einhrn LH. Cisplatin, diagnosis and treatment [ J ]. Ann Intern Med 1984,100(5) :704.
3Ozls RF. Current status of chemotherapy for ovarian cancer [ J ]. Semin Oncol ; 1995,22:61.
4Cvitkovic E, Spaulding J Bethune V, et al Improvement of sicdichlorodiamineplatinum (NSC119875) therapeutic index in an animal model [J]. Cancer 1977,39(4) : 1357.
5Oettle H. Treatment of chemotherapy - induced nausea and vomiting [ J ]. J Cancer Res Clin Oncol, 2001,127(6) :340- 345.
6Lo kich J. What is the “best” platinum: Cisplatin, Carboplatin, or Oxaliplatin [J]. Cancer Invest,2001,19(7) :756.
7Schellens JHM, Ma J, Planting ASTL, el al. Relationship between the exposure to cisplatin DNA - adduct formation in leucocytes with solid tumors [ J ]. Br J Cancer. 1996,73 (12) : 1569.
8David R,John Crowley G, Robert B. el al Evaluation of cisplatin intensity in metastatatic non - small - cell lung cancer: A phase Ⅲ study of the Southwest Ontology Group [ J ]. J Clin Cncol. 1993,11 (5) : 873 - 878.
9Ozols RF, Corden BJ ,Jacobj. el al. High does cisplatin in hypertonic saline[J] .Ann Int Med. 1984,100(1) :19- 24.
10GO. R. S, Adjei. A. A. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin [J ] . J Clin Oncol, 1999, 17(1):409-422.
